The Role of Microorganisms in Medicine

Historical Context

Microorganisms and their derivatives have played a significant role in medicine for more than two centuries. The discovery of penicillin marked a pivotal moment, leading to the widespread use of antibiotics—substances produced by bacteria, fungi, and other microbes—to treat various bacterial infections. Common ailments addressed by antibiotics include colds, syphilis, tuberculosis, salmonella, and certain types of meningitis.

Probiotics and Their Impact

Probiotics, which are live bacteria typically administered through fermented dairy products, influence the intricate network of microbial interactions within the human gut. Their effects can be both beneficial and detrimental to health. Currently, probiotics are utilized to manage conditions such as diarrhea, lactose intolerance, inflammation, cardiovascular diseases, and colon cancer.

Research Focus: Nutritional Disorders

Both antibiotics and probiotics have garnered attention as potential treatments for nutritional disorders. The following sections summarize recent research findings and pose questions for future exploration.

Obesity and Malnutrition

Understanding Obesity

Human metabolism is characterized by a complex array of reactions that must remain balanced. Obesity occurs when this balance is disrupted, often due to factors such as sedentary lifestyles, increased fat consumption, social influences, family history, and genetic predisposition. Notably, imbalances in gut microbiota have been associated with obesity, as these microorganisms play key roles in food absorption and energy metabolism. Disruptions in microbiota composition can lead to obesity, with certain infections linked to higher obesity rates among children.

Global Undernourishment

Contrastingly, severe undernourishment primarily affects the developing world, impacting approximately 30% of the global population, with a significant proportion being children.

Antibiotics and Weight

Clinical Insights

Recent clinical studies have explored the relationship between antibiotic use and weight changes. Findings include:

– Amoxicillin and cefdinir are associated with weight gain in malnourished children.
– Clarithromycin, used for Helicobacter pylori infection, correlates with weight gain.
– Vancomycin, for endocarditis treatment, contributes to weight gain in adults.
– Erythromycin has been linked to increased weight in preterm infants.
– Sulfonamides and Co-trimoxazole show a connection to weight gain.
– Penicillin is associated with weight loss in children.

Generally, antibiotics administered to newborns within the first six months are correlated with increased obesity risk, while those given between six to 23 months do not show the same association.

Probiotics and Weight

Research Findings

Probiotics have emerged as a focal point in research concerning obesity and malnutrition. Notable findings indicate that some probiotic strains can lead to weight increases, while others may assist in weight reduction.

– Substantial weight gain has been observed with strains such as Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium breve, and others, sometimes within just three days.
– Lactobacillus rhamnosus can prevent excessive weight gain in infants if administered within the first six months.
– Pregnant women receiving Lactobacillus rhamnosus and Bifidobacterium lactis do not pass any weight gain benefits to their children.
– Weight loss has been noted with strains like Streptomyces toxytricini and Lactobacillus gasseri.

Future Research Considerations

Unresolved Issues

The exploration of antibiotics and probiotics as agents for weight modification is still in its infancy and presents many unanswered questions. While antibiotics can temporarily rectify microbiota imbalances, their prolonged use may result in lasting negative changes.

Key areas requiring further investigation include:

– The potential depletion of beneficial gut microorganisms due to antibiotic use, which has been observed with various antibiotics affecting intestinal flora.
– The impact of bacteriocins, substances produced by bacteria that can harm other strains, especially in the context of antibiotic overuse.
– The variability in probiotic efficacy among individuals remains unexplored.
– The long-term effects and potential adverse outcomes of probiotics require further study, as some have been linked to increased disease relapse rates and higher mortality in specific patient populations.

Despite existing knowledge gaps, the market for probiotics continues to grow. Some experts advocate for their reclassification as pharmaceuticals to ensure rigorous clinical testing.

Antibiotics in Agriculture

The established practice of using antibiotics as growth promoters in livestock necessitates scrutiny regarding potential health implications for consumers of animal products.

As interest in antibiotics and probiotics as treatments for obesity and malnutrition rises, future research aims to clarify these complex issues.

Reference: Angelakis, E., Merhej, V., and Raoult, D. “Related actions of probiotics and antibiotics on gut microbiota and weight modification.” The Lancet: Infectious Diseases 13(10): 889-899, October 2013. Written by Julia Yusupova.